Abstract：
:The human trk oncogene (originally identified in a colon carcinoma) was activated by a genetic rearrangement which resulted in replacement of the extracellular ligand-binding domain of the proto-trk transmembrane receptor by non-muscle tropomyosin sequences. The product of the trk oncogene, a protein of 70 kDa (p70trk), possesses tyrosine-specific protein kinase activity, is autophosphorylated in vitro on tyrosine and is phosphorylated on serine, threonine and tyrosine residues in trk-transformed cells. By site-directed mutagenesis of trk oncogene cDNA, the codon for lysine (367) at the putative ATP-binding site was changed to that for methionine and the codons for tyrosines (503 and 504) at the putative autophosphorylation sites were changed to those for phenylalanine. Replacement of Lys-367 by methionine results in a biologically inactive, kinase-negative mutant. Phe-ala mutants of trk showed drastically reduced ability to induce morphologic transformation, anchorage-independent growth and tumorigenicity in mouse NIH3T3 cells and showed reduced in vitro tyrosine kinase activity when assayed by autophosphorylation and phosphorylation of histone as exogenous substrate. The present study indicates the role of these specific conserved residues in regulating the biochemical and biological properties of p70trk oncoprotein.
journal_name
Oncogenejournal_title
Oncogeneauthors
Mitra Gsubject
Has Abstractpub_date
1991-12-01 00:00:00pages
2237-41issue
12eissn
0950-9232issn
1476-5594journal_volume
6pub_type
杂志文章相关文献
ONCOGENE文献大全abstract：:Resistance to TGF-beta1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-beta inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the TGF-beta inhibitory signalin...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202118
更新日期：1998-10-15 00:00:00
abstract：:Transcription from the rat TGF alpha promoter initiates at two predominant sites (-188 and -58) in a G+C-rich region that does not contain TATA or CAAT motifs. Previous studies using transfected reporter constructs implicated the transcription factor Sp1 in active expression from the promoter, particularly from the -5...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-11-01 00:00:00
abstract：:Non-small cell lung cancer remains a highly lethal malignancy. Using the tamoxifen inducible Hnf1b:CreERT2 (H) transgenic mouse crossed to the LsL-KrasG12D (K) transgenic mouse, we recently discovered that an Hnf1b positive cell type in the lung is sensitive to adenoma formation when expressing a mutant KrasG12D allel...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/s41388-019-1031-z
更新日期：2020-01-01 00:00:00
abstract：:Telomerase expression is the hallmark of tumor cells in which this ribonucleoprotein complex preserves chromosome integrity by maintaining telomere length and thereby prevents cell death. However, recent data support a role of the combination of p53 and telomerase inactivation in initiating genetic instability that pr...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206468
更新日期：2003-06-12 00:00:00
abstract：:The transcription factor DRTF1/E2F is implicated in the control of cellular proliferation due to its interaction with key regulators of cell cycle progression, such as the retinoblastoma tumour suppressor gene product and related pocket proteins, cyclins and cyclin-dependent kinases. DRTF1/E2F DNA binding activity ari...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1995-07-06 00:00:00
abstract：:As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional co...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210688
更新日期：2008-01-24 00:00:00
abstract：:Tumor suppressor Pdcd4 has recently been shown to inhibit invasion by activating activator protein-1 (AP-1); however, little is known of the functionally significant Pdcd4-target genes. The urokinase receptor (u-PAR) promotes invasion/metastasis, and is associated with poor cancer-patient survival. The present study w...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210234
更新日期：2007-07-05 00:00:00
abstract：:The role of the hepatitis B virus protein HBx in liver cell proliferation and apoptosis remains controversial. Using a transgenic mouse model, we have recently shown that HBx stimulates the apoptotic turnover of hepatocytes, independently of p53. In this paper, we tested whether the proapoptotic function of HBx can in...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205110
更新日期：2002-01-17 00:00:00
abstract：:Recent studies suggest that the action of platelet-activating factor (PAF), a potent phospholipid modulator of allergic and inflammatory reactions, is diverse and functions as a modulator of a variety of physiological and pathological events in many cell types and tissues. Its role (if any) in modulating the prolifera...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206348
更新日期：2003-04-10 00:00:00
abstract：:The DNA methylation pattern of a cell is exquisitely controlled during early development resulting in distinct methylation patterns. The tight control of DNA methylation is released in the cancer cell characterized by a reversal of methylation states. CpG island associated genes, in particular tumour suppressor or rel...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1205598
更新日期：2002-08-12 00:00:00
abstract：:Previous observations suggest expression of cyclooxygenase-2 to convey macrophage protection towards apoptotic cell death. We reasoned prostaglandin formation and in turn a cAMP increase as the underlying protective principle. Here we report that exposure of macrophages to lipopolysaccharide/interferon-gamma or lipoph...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201926
更新日期：1998-07-23 00:00:00
abstract：:A minimal transcription activation domain of the v-Myb oncoprotein was initially mapped to a central cluster of charged residues using GAL4-Myb fusion proteins. This region has been proposed to interact directly with the CBP co-activator in animal cells. Regions flanking this central domain of v-Myb are required for t...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205236
更新日期：2002-02-28 00:00:00
abstract：:The p53 tumor suppressor gene continues to be distinguished as the most frequently mutated gene in human cancer; this gene can be found mutated in up to 50% of human tumors of diverse histological type. It is generally accepted that the ability of p53 to induce either growth arrest or programmed cell death in response...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1209367
更新日期：2006-03-13 00:00:00
abstract：:Neuroblastoma is the second most common pediatric malignancy, characterized by a high rate of unexplained spontaneous remissions. Much progress has been made in understanding neuroblastoma differentiation triggered by certain agents such as retinoic acid. However, little is known about the signalling pathways that lea...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208494
更新日期：2005-05-05 00:00:00
abstract：:Wnt genes encode a set of structurally related cell surface glycoproteins that appear to have roles in cell-cell signalling. The ectopic expression of several murine Wnt genes has been implicated in the transformation of mammary epithelial and the onset of mammary tumours. Wnt11 is expressed in the developing embryo i...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-06-20 00:00:00
abstract：:Glypican-3 (GPC3) is a membrane-bound heparan sulfate proteoglycan that is mutated in the Simpson-Golabi-Behmel syndrome. This is an X-linked condition characterized by overgrowth, and various visceral and skeletal dysmorphisms. The phenotype of the Simpson-Golabi-Behmel syndrome patients and GPC3-deficient mice, as w...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204925
更新日期：2001-11-01 00:00:00
abstract：:GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal r...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2008.480
更新日期：2009-03-12 00:00:00
abstract：:BRCA1 is a tumour suppressor gene implicated in the predisposition to early onset breast and ovarian cancer. We have generated cell lines with inducible expression of BRCA1 to evaluate its role in mediating the cellular response to various chemotherapeutic drugs commonly used in the treatment of breast and ovarian can...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204712
更新日期：2001-09-27 00:00:00
abstract：:Activation of cellular transcriptional responses, mediated by hypoxia-inducible factor (HIF), is common in many types of cancer, and generally confers a poor prognosis. Known to induce many hundreds of protein-coding genes, HIF has also recently been shown to be a key regulator of the non-coding transcriptional respon...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2014.378
更新日期：2015-08-20 00:00:00
abstract：:We report the detailed molecular characterization of a human parathyroid adenoma with a clonal parathyroid hormone gene rearrangement. This rearrangement is similar to one we characterized recently in an independent adenoma. In these two, plus a third partially characterized adenoma, one allele of the PTH gene, on 11p...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1991-03-01 00:00:00
abstract：:In an effort to understand the mechanisms governing the regulation of the mouse Ron receptor gene, a mouse genomic library was screened and overlapping clones coding for the Ron gene and flanking DNA were identified. Continuous DNA sequence was obtained for approximately 16.4 kilobases. The gene, from the initiator me...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201508
更新日期：1998-01-08 00:00:00
abstract：:We studied the role of the mitogen-activated protein kinase (MAPK) pathway in the regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in breast tumor MCF-7 cells. We found that addition of a protein kinase C (PKC) activator to MCF-7 cultures prevented TRAIL-induced apoptosi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205523
更新日期：2002-06-20 00:00:00
abstract：:Loss of the tumor suppressive effect of transforming growth factor-beta (TGF-beta) has been commonly found at later stages in carcinogenic progression. Although the genes encoding TGF-beta receptors and Smads have been found genetically altered in certain human cancers, no mutation in Smad3 has been observed. Therefor...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1207259
更新日期：2004-02-19 00:00:00
abstract：:The cytoplasmic tyrosine kinase Src has been implicated in signal transduction induced by growth factors and integrins. Src also shows oncogenic activity when deregulated. Accumulating evidence indicates that the tyrosine kinase Abl is an important substrate for Src signalling in normal cells. Here we show that Abl is...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210543
更新日期：2007-11-15 00:00:00
abstract：:In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ERalpha) and its role in hormonal therapy and endocrine resistance. FOXM1 protein and mRNA expression was regulated by ER-ligands, including estrogen, tamoxifen (OHT) and fulvestrant (ICI182780; ICI) in breast carcinoma cell ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.47
更新日期：2010-05-20 00:00:00
abstract：:Non-small cell lung cancer (NSCLC) accounts for ∼80% of all lung cancers. Although some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2011.260
更新日期：2012-02-02 00:00:00
abstract：:Insights into the pathogenesis of human leukemia have relied heavily on studies of the identified chromosomal translocations found in this group of malignant diseases. Acquired, balanced translocations in acute myelogenous leukemia (AML) generally involve transcriptional regulatory genes, whereas in the myeloprolifera...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1207673
更新日期：2004-05-24 00:00:00
abstract：:The Epstein-Barr virus (EBV) encoded Latent Membrane Protein-1 (LMP1) mimics a constitutively active receptor molecule, and has been shown to activate NF-kappaB and the MAPK and JNK pathways. Two regions within the cytosolic domain of LMP1 have been found to effect cell signalling. One of these, the carboxy-terminal a...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202144
更新日期：1998-11-05 00:00:00
abstract：:DNA damage response (DDR), the guardian of genomic integrity, emerges as an oncogene-inducible biological barrier against progression of cancer beyond its early stages. Recent evidence from both cell culture and animal models as well as analyses of clinical specimens show that activation of numerous oncogenes and loss...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1210881
更新日期：2007-12-10 00:00:00
abstract：:The adenovirus E1A protein has been shown to be involved in the potentiation of apoptosis induced by chemotherapeutic agents, yet the molecular events of E1A-mediated apoptosis are not very clear. A recent report has suggested that deamidation of the Bcl-X(L) protein inhibits its antiapoptotic ability and leads to apo...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1209294
更新日期：2006-04-27 00:00:00
